healingMolecular Weight: 1419.5Reviewed: 2026-03-26

BPC-157

Body Protection Compound-157

A 15 amino acid peptide derived from gastric BPC protein. Studied for regenerative properties and tissue healing.

Quick Answer

BPC-157 is a flagship healing-peptide topic because readers want to know whether the enormous online claim volume is actually supported by solid human evidence.

Shop BPC-157

Mechanism

Peptide with regenerative potential and tissue healing properties. Modulates growth factors and promotes angiogenesis.

Half-Life

4-6 hours

Administration

Subcutaneous,Intramuscular

Technical Protocol

BPC-157: Comprehensive Research Guide

Overview

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide derived from gastric juice protein (BPC). This stable gastric pentadecapeptide has demonstrated remarkable regenerative potential across multiple tissue types in preclinical research.

Mechanism of Action

BPC-157 operates through multiple interconnected pathways:

Growth Factor Modulation

  • VEGF (Vascular Endothelial Growth Factor): BPC-157 significantly upregulates VEGF expression, promoting angiogenesis (formation of new blood vessels) essential for tissue repair.
  • FGF (Fibroblast Growth Factor): Enhances fibroblast proliferation and collagen synthesis.
  • EGF (Epidermal Growth Factor): Supports epithelial cell regeneration.

Research Applications

Tendon & Ligament Healing

BPC-157 has shown remarkable efficacy in research models of tendon injuries.

Muscle Recovery

  • Reduces muscle damage markers
  • Accelerates recovery from muscle contusions
  • Improves muscle fiber regeneration

This information is for research and educational purposes only.

Answer-First Research Snapshot

Evidence

This page should win by separating preclinical promise from real-world overclaiming more clearly than low-quality recovery sites do.

Dosage Context

When users search dosage, they are often really looking for confidence and legitimacy. The page should redirect that intent toward evidence quality, study type, and protocol assumptions.

Status

Keep BPC-157 framed as a high-curiosity research topic with limited human outcome depth for many popular claims.

Lead with evidence hierarchy, not miracle language.

Compare directly with TB-500 because that is how users search.

Tie the page to safety and regulatory education to keep the tone trustworthy.

Peer-Reviewed Citations

Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease

Sikiric P, et al. • World J Gastroenterol (2017)

Access Research

BPC 157 and standard angiogenic growth factors. Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing

Sikiric P, et al. • Curr Pharm Des (2018)

Access Research

Pentadecapeptide BPC 157 and its effects on wound healing

Seiwerth S, et al. • Inflammopharmacology (2018)

Access Research

Frequently Asked Questions

Why does BPC-157 need a stronger evidence-first page?

Because the public narrative is much louder than the human clinical database for many of the uses people care about. The page should answer that gap directly.

What should BPC-157 be compared with most often?

Usually TB-500, because recovery-focused users commonly search the two together and expect a clear difference in mechanism and evidence strength.

How should BPC-157 be stored?

Store at 2-8°C, protect from light

Continue the Research Path

Source BPC-157 for Your Research

Third-party tested, EU-shipped, certificate of analysis included. High-purity BPC-157 available from our verified research partner.

Shop BPC-157

Related Healing Peptides